Interim safety analysis of the DANTE trial: Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma-A randomized, open-label phase II trial of the German Gastric Group at the AIO and SAKK.
Zeitschriftentitel:
J Clin Oncol
Jahr:
2020
Band / Volume:
38 Suppl S
Heft / Issue:
15
Print-ISSN:
0732-183X
TUM Einrichtung:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)